Phase 1 study of pembrolizumab plus chemotherapy in Japanese patients with extensive-stage small-cell lung cancer.
Naoyuki NogamiTakaaki TokitoYoshitaka ZenkeMiyako SatouchiTakashi SetoHideo SakaJunko OhtaniShirong HanKazuo NoguchiMakoto NishioPublished in: Investigational new drugs (2024)
ClinicalTrials.gov , NCT01840579.